Published a paper on strategies to combat Covid-19 with Nichi Glucan- food supplement

GN Corporation published a paper (review article) on the potential of our product “Nichi Glucan” containing AFO-202 β-glucan to prevent novel coronavirus infection (COVID-19) in Frontiers in Immunology Journal.

Nichi Glucan is a functional dietary supplement that has been shown through years of research to have the following unique effects;

(1) It enhances the immune system, which protects the body from pathogens (bacteria, viruses, fungi, etc.) that have invaded the body.

(2) It has a regulatory control action on inflammatory cytokines (especially IL-6), a biomarker that induces cytokine storms.

The paper argues that “Nichi Glucan” may be a candidate for a beneficial functional dietary supplement until an effective vaccine or drug for the prevention of novel coronavirus infection (COVID-19) becomes available. The paper also proposes that it could be applied in clinical trials for patients actually infected with a novel coronavirus (SARS-CoV-2).

To get more info about our product Nichi Glucan, please visit

Covid imm Nichi Glucan

Other Press release

Other articles